Stockreport

ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF Recent amendment to HealthCare Royalty financing agreement increases strategic flexibility Fourth quarter and full year 2025 net product revenue of approximately $22. [Read more]